Current cysteine bioconjugation strategies for protein-drug conjugates synthesis often yield heterogeneous and poorly stable products. Here, the authors use carbonylacrylic derivatives to selectively modify cysteine residues and synthesize biologically functional antibody conjugates highly stable in plasma.
- Barbara Bernardim
- Pedro M.S.D. Cal
- Gonçalo J. L. Bernardes
